SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 5107.00 millions during the quarter ended September 2021. The figure stood at Rs. 5151.60 millions during the year-ago period.A big decline of -41.80% was reported for the quarter ended September 2021 to Rs. 406.10  millions from Rs. 697.80 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 700.20 millions from 1092.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 5107.00 5151.60 -0.87 10164.90 9907.10 2.60 19148.90 16349.20 17.12
Other Income 8.90 2.60 242.31 25.30 15.00 68.67 64.20 10.60 505.66
PBIDT 700.20 1092.30 -35.90 1459.30 2265.70 -35.59 4076.90 2454.60 66.09
Interest 51.10 69.80 -26.79 92.20 133.70 -31.04 226.10 322.00 -29.78
PBDT 649.10 1022.50 -36.52 1367.10 2132.00 -35.88 3853.00 2216.40 73.84
Depreciation 118.00 119.70 -1.42 235.60 238.90 -1.38 476.00 466.70 1.99
PBT 531.10 902.80 -41.17 1131.50 1893.10 -40.23 3377.00 1749.70 93.00
TAX 125.00 205.00 -39.02 270.00 465.00 -41.94 800.00 393.00 103.56
Deferred Tax -5.00 -15.00 -66.67 -10.00 -5.00 100.00 -45.00 -102.50 -56.10
PAT 406.10 697.80 -41.80 861.50 1428.10 -39.68 2577.00 1356.70 89.95
Equity 926.00 932.00 -0.64 926.00 932.00 -0.64 932.00 233.00 300.00
PBIDTM(%) 13.71 21.20 -35.34 14.36 22.87 -37.23 21.29 15.01 41.81

Aarti Drugs Share Price

396.40 0.65 (0.16%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: